We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Clorox's International Expansion Key to Its Long-Term Success?
Read MoreHide Full Article
Key Takeaways
CLX's International segment sales rose 7% to $294M in fiscal Q2 2026, with organic sales up 5%.
Clorox posted 48% adjusted EBIT growth in the segment, driven by higher sales and cost savings.
CLX expects international organic sales growth of 15% in Q4 and about 8.2% for fiscal 2026.
The Clorox Company’s (CLX - Free Report) international expansion is emerging as a critical lever for its long-term success, particularly as growth in its mature domestic markets begins to slow. The company is increasingly focused on scaling its presence in high-growth emerging markets such as Latin America and Asia, where rising middle-class populations and shifting hygiene habits are driving stronger demand for branded household and cleaning products.
A broader international presence could help Clorox reduce its reliance on the U.S. market, unlock new growth avenues and support more sustainable long-term revenue expansion. However, successfully executing this strategy will depend on the company’s ability to navigate currency volatility, regulatory complexities and competitive pressures in these diverse markets. The company aims to unlock greater potential in its International segment by building on the success of its Go Lean strategy, emphasizing product innovation and operational efficiency across key global markets.
In second-quarter fiscal 2026, CLX’s International segment saw a 7% rise in net sales of $294 million due to price mix, favorable foreign exchange rates and increased volumes. Organic sales also grew 5%. Segment adjusted EBIT surged 48%, mainly due to higher net sales and cost savings. We expect CLX’s international segment’s sales to increase 5% in the third quarter and 0.5% in fiscal 2026.
To succeed internationally, Clorox must carefully balance brand recognition with pricing power, while continuing to invest in localized product innovation and adapting to diverse regulatory environments across markets. Building strong brand equity is essential, but maintaining competitive pricing is equally important, particularly in emerging economies where consumers remain price sensitive. Currency fluctuations, supply-chain complexities and economic volatility in emerging markets further complicate its global push, demanding strategic agility and long-term commitment.
Looking ahead, international expansion remains a promising pathway for Clorox to diversify revenue streams. With targeted investments and a disciplined approach, the company can position itself as a global consumer staples contender. In the long run, success abroad could be instrumental in driving both top-line growth and shareholder value.
CLX’s Price Performance, Valuation & Estimates
Shares of Clorox have gained 12.6% in the past three months compared with the industry’s growth of 10.6%
Image Source: Zacks Investment Research
From a valuation standpoint, CLX is trading at a forward price-to-earnings ratio of 17.40X compared with the industry’s average of 19.03X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CLX’s fiscal 2026 earnings implies a year-over-year decline of 23.5%, while that of fiscal 2027 shows growth of 15.3%. The company’s EPS estimate for fiscal 2026 has moved north, while that of fiscal 2027 has moved south in the past 30 days.
Image Source: Zacks Investment Research
Clorox stock currently carries a Zacks Rank #3 (Hold).
The Zacks Consensus Estimate for Freshpet’s current financial-year sales indicates growth of 8.5% from the prior-year level. FRPT delivered a trailing four-quarter earnings surprise of 50%, on average.
Nomad Foods Limited (NOMD - Free Report) , which manufactures and distributes frozen foods, currently carries a Zacks Rank of 2.
The Zacks Consensus Estimate for Nomad Foods’ current financial-year earnings is expected to rise 6.2% from the year-ago reported figure. NOMD delivered a trailing four-quarter earnings surprise of 2.9%, on average.
Medifast, Inc. (MED - Free Report) , which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED missed the average earnings surprise by a sharp margin in the trailing four quarters.
The Zacks Consensus Estimate for Medifast’s current financial-year earnings indicates growth of 30.5% from the year-ago number.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Is Clorox's International Expansion Key to Its Long-Term Success?
Key Takeaways
The Clorox Company’s (CLX - Free Report) international expansion is emerging as a critical lever for its long-term success, particularly as growth in its mature domestic markets begins to slow. The company is increasingly focused on scaling its presence in high-growth emerging markets such as Latin America and Asia, where rising middle-class populations and shifting hygiene habits are driving stronger demand for branded household and cleaning products.
A broader international presence could help Clorox reduce its reliance on the U.S. market, unlock new growth avenues and support more sustainable long-term revenue expansion. However, successfully executing this strategy will depend on the company’s ability to navigate currency volatility, regulatory complexities and competitive pressures in these diverse markets. The company aims to unlock greater potential in its International segment by building on the success of its Go Lean strategy, emphasizing product innovation and operational efficiency across key global markets.
In second-quarter fiscal 2026, CLX’s International segment saw a 7% rise in net sales of $294 million due to price mix, favorable foreign exchange rates and increased volumes. Organic sales also grew 5%. Segment adjusted EBIT surged 48%, mainly due to higher net sales and cost savings. We expect CLX’s international segment’s sales to increase 5% in the third quarter and 0.5% in fiscal 2026.
To succeed internationally, Clorox must carefully balance brand recognition with pricing power, while continuing to invest in localized product innovation and adapting to diverse regulatory environments across markets. Building strong brand equity is essential, but maintaining competitive pricing is equally important, particularly in emerging economies where consumers remain price sensitive. Currency fluctuations, supply-chain complexities and economic volatility in emerging markets further complicate its global push, demanding strategic agility and long-term commitment.
Looking ahead, international expansion remains a promising pathway for Clorox to diversify revenue streams. With targeted investments and a disciplined approach, the company can position itself as a global consumer staples contender. In the long run, success abroad could be instrumental in driving both top-line growth and shareholder value.
CLX’s Price Performance, Valuation & Estimates
Shares of Clorox have gained 12.6% in the past three months compared with the industry’s growth of 10.6%
Image Source: Zacks Investment Research
From a valuation standpoint, CLX is trading at a forward price-to-earnings ratio of 17.40X compared with the industry’s average of 19.03X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CLX’s fiscal 2026 earnings implies a year-over-year decline of 23.5%, while that of fiscal 2027 shows growth of 15.3%. The company’s EPS estimate for fiscal 2026 has moved north, while that of fiscal 2027 has moved south in the past 30 days.
Image Source: Zacks Investment Research
Clorox stock currently carries a Zacks Rank #3 (Hold).
Stocks to Consider in the Consumer Staples Space
Freshpet, Inc. (FRPT - Free Report) , which is a pet food company, currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Freshpet’s current financial-year sales indicates growth of 8.5% from the prior-year level. FRPT delivered a trailing four-quarter earnings surprise of 50%, on average.
Nomad Foods Limited (NOMD - Free Report) , which manufactures and distributes frozen foods, currently carries a Zacks Rank of 2.
The Zacks Consensus Estimate for Nomad Foods’ current financial-year earnings is expected to rise 6.2% from the year-ago reported figure. NOMD delivered a trailing four-quarter earnings surprise of 2.9%, on average.
Medifast, Inc. (MED - Free Report) , which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED missed the average earnings surprise by a sharp margin in the trailing four quarters.
The Zacks Consensus Estimate for Medifast’s current financial-year earnings indicates growth of 30.5% from the year-ago number.